A prospective evaluation of the tolerability and safety of Stalevo™ (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off

被引：0
|
作者：
Koller, W
Silver, D
Guarnieri, M
Hubble, J
Rabinowicz, A
机构：
来源：
MOVEMENT DISORDERS | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P577
引用
收藏
页码：S205 / S206
页数：2
相关论文
共 50 条
  • [1] An open-label evaluation of the tolerability and safety of Stalevo® (carbidopa, levodopa and entacapone) in Parkinson’s disease patients experiencing wearing-off
    W. Koller
    M. Guarnieri
    J. Hubble
    A. L. Rabinowicz
    D. Silver
    [J]. Journal of Neural Transmission, 2005, 112 : 221 - 230
  • [2] An open-label evaluation of the tolerability and safety of Stalevo® (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off
    Koller, W
    Guarnieri, M
    Hubble, J
    Rabinowicz, AL
    Silver, D
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (02) : 221 - 230
  • [3] Efficacy and tolerability of Stalevo® in patients with Parkinson's disease experiencing wearing-off
    Jost, WH
    Zeiler, B
    Nüdling, S
    Elsner, A
    Enk, C
    Roscher, T
    [J]. AKTUELLE NEUROLOGIE, 2005, 32 : S318 - S325
  • [4] Stalevo® Effective Therapy for Parkinson's Wearing-off with the 6 Dose Levels of Levodopa/Carbidopa/Entacapone
    Fuchs, G. A.
    Roscher, T.
    [J]. AKTUELLE NEUROLOGIE, 2011, 38 (04) : B4 - B11
  • [5] Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off
    Mikko Kuoppamäki
    Mika Leinonen
    Werner Poewe
    [J]. Journal of Neural Transmission, 2015, 122 : 1709 - 1714
  • [6] Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off
    Kuoppamaki, Mikko
    Leinonen, Mika
    Poewe, Werner
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (12) : 1709 - 1714
  • [7] Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo*) compared to standard care in UK Parkinson's disease patients with wearing-off
    Findley, LJ
    Lees, A
    Apajasalo, M
    Pitkänen, A
    Turunen, H
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (07) : 1005 - 1014
  • [8] Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson's disease experiencing mild wearing-off: a randomised, double-blind trial
    Tolosa, Eduardo
    Hernandez, Basilio
    Linazasoro, Gurutz
    Jose Lopez-Lozano, Juan
    Mir, Pablo
    Marey, Jose
    Kulisevsky, Jaime
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2014, 121 (04) : 357 - 366
  • [9] Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial
    Eduardo Tolosa
    Basilio Hernández
    Gurutz Linazasoro
    Juan José López-Lozano
    Pablo Mir
    José Marey
    Jaime Kulisevsky
    [J]. Journal of Neural Transmission, 2014, 121 : 357 - 366
  • [10] Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone
    Reichmann, Heinz
    Emre, Murat
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (02) : 119 - 131
12345